IBEX vs TECH · P/E 13, rev $558.3M vs P/E 65, rev $1.22B
IBEX Ltd (IBEX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
IBEX Ltd (IBEX) is a information technology services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported IBEX revenue for 2025-06-30 was $558.3M. Net income was $36.9M. Revenue was up 9.8% from 2024-06-30 to 2025-06-30. IBEX currently screens at market cap $388.5M and trailing P/E 12.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
IBEX currently screens at market cap $388.5M and trailing P/E 12.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the IBEX and TECH stock pages for the full models.
Not investment advice.